Rose Bengal PDAT

About VisiRose

VisiRose is a private, pre-revenue biotech company developing Rose Bengal Photodynamic Antimicrobial Therapy (RB PDAT) for ocular infections, primarily infectious keratitis. The technology, licensed from the University of Miami's Bascom Palmer Eye Institute, uses a topical photosensitizer activated by light to destroy a wide range of pathogens without known resistance. With a seasoned management team connected to its parent company Provectus Biopharmaceuticals, VisiRose aims to address a significant global health need where current treatments are often invasive, ineffective against drug-resistant strains, or inaccessible.

Therapeutic Areas